Typhoid Fever Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Key Companies – Acer Therapeutics, Aegela BioTherapeutics, Ultragenyx

Typhoid Fever Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Key Companies - Acer Therapeutics, Aegela BioTherapeutics, Ultragenyx
DelveInsight Business Research LLP
DelveInsight’s “Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Typhoid Fever, epidemiology insights, Typhoid Fever market trends, therapies and key companies working in the Typhoid Fever Market in the 7MM.

Typhoid Fever Overview

Typhoid fever is a bacterial infection that can spread throughout the body, affecting many organs. Without prompt treatment, it can cause serious complications and can be fatal. It’s caused by a bacterium called Salmonella typhi, which is related to the bacteria that cause salmonella food poisoning.

Typhoid Fever Epidemiology Insights

  • According to  Van Leung-Pineda (2019), the prevalence of Typhoid Fever in the US is approximately 1 in 35,000, with two-thirds having symptoms in the neonatal period. The mortality rate of Typhoid Fever is 24% in neonatal cases and 11% in later onset cases.

  • According to Mageed G (2015), the prevalence of Typhoid Fever in EU-4 was 1.89 per 100,000 in the 0-4-year-old age group, 1.63 per 100,000 in the 10-14-year-old age group, and 1.57 per 100,000 in the 15-17-year-old age group. 

  • The clinical manifestations are variable. The most severe type is neonatal-onset UCD, which occurs within 28 days after birth and is characterized by vomiting, food refusal, lethargy, tachypnea, impaired consciousness, and multiorgan failure. 

  • According to Batshaw et al. (2014), the mortality rate of UCD is 24% in neonatal onset cases and 11% in late-onset cases.

Click here to learn more about the Typhoid Fever Market Landscape

The Report Covers the Typhoid Fever Epidemiology Segmented by:

  • Typhoid Fever incident cases 

  • Typhoid Fever diagnosed cases 

  • Typhoid Fever treatment cases 

  • Typhoid Fever onset-specific cases 

Typhoid Fever Market Outlook 

The Typhoid Fever market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Typhoid Fever market trends by analyzing the impact of current Typhoid Fever therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. This segment gives a thorough detail of the Typhoid Fever market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. According to DelveInsight, the Typhoid Fever market in 7MM is expected to witness a major change in the study period 2019-2032.

 Key Companies Working in the Typhoid Fever Market

  • AcerTherapeutics

  • Aeglea BioTherapeutics

  • Ultragenyx Pharmaceutical

  • And many others 

Typhoid Fever Therapies Covered and Analyzed in the Report:

  • ACER-001

  • AEB1102

  • DTX301

  • And many others 

Learn more about the Key Companies and Emerging Therapies in the Typhoid Fever Market

 Table of Contents 

  1. Key Insights 

  2. Typhoid Fever Introduction 

  3. Executive Summary of Typhoid Fever  

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Typhoid Fever Emerging Therapies

  7. Typhoid Fever Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Typhoid Fever Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services


Posted

in

by

Tags: